Z-2798-2020 Class II Terminated
FDA device recall Z-2798-2020 was initiated by Intrinsic Therapeutics, Inc. on Jul 24, 2020 and is designated Class II. Reason for recall: The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM. The recall status is terminated (terminated Sep 16, 2020). Affected quantity: 110 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 19, 2020
- Initiation Date
- Jul 24, 2020
- Termination Date
- Sep 16, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 110 units
Product description
Barricaid Annual Closure Device (ACD) BAR-A8-8MM - Product Usage: The Barricaid¿ ACD is indicated for reducing the incidence of reherniation, and reoperation in skeletally mature patients with radiculopathy (with or without back pain) attributed to a posterior or posterolateral herniation, and confirmed by history, physical examination and imaging studies which demonstrate neural compression using MRI to treat a large annular defect (between 4-6 mm tall and between 6-10 mm wide) following a primary discectomy procedure (excision of herniated intervertebral disc) at a single level between L4 and S1.
Reason for recall
The catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.
Distribution pattern
US Nationwide distribution.
Code information
Catalog #: BAR-A8-8MM Part #: 2730815-A8 Lot #: 06112001, 06152001
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2798-2020
- openFDA file date
- Nov 17, 2026
- Loaded by RegDataLab
- Nov 18, 2026